Immunovant, Inc. (IMVT) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$25.04
Day's range
$26.84

Immunovant Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 08/13/2026 16.19 M $623.66 M   -4.49% 7.95%
DEEP TRACK CAPITAL, LP 08/14/2026 9.34 M $359.91 M   -18.96% 4.59%
BLACKROCK, INC. 08/07/2026 7.18 M $276.68 M   9.22% 3.53%
FARALLON CAPITAL MANAGEMENT LLC 08/14/2026 5.81 M $223.67 M   275.49% 2.85%
BAKER BROS. ADVISORS LP 08/14/2026 5.44 M $209.42 M   -0.42% 2.67%
STATE STREET CORP 08/07/2026 4.62 M $177.89 M   1.74% 2.27%
MORGAN STANLEY 08/13/2026 4.53 M $174.73 M   16.97% 2.23%
TCG CROSSOVER MANAGEMENT, LLC 08/14/2026 4.46 M $171.77 M   0.00% 2.19%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 3.91 M $150.67 M   5.55% 1.92%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 3.64 M $140.20 M   0.51% 1.79%
JENNISON ASSOCIATES LLC 08/03/2026 3.31 M $127.54 M   3.55% 1.63%
RTW INVESTMENTS, LP 08/14/2026 3.18 M $122.44 M   0.00% 1.56%
TWO SEAS CAPITAL LP 08/12/2026 3.15 M $121.31 M   -1.67% 1.55%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 2.33 M $89.80 M   -13.00% 1.14%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 2.23 M $86.12 M   6.81% 1.10%
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. 08/14/2026 2.22 M $85.62 M   -38.49% 1.09%
WOODLINE PARTNERS LP 08/14/2026 1.98 M $76.13 M   0.00% 0.97%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 1.83 M $70.48 M   438.63% 0.90%
GOLDMAN SACHS GROUP INC 08/14/2026 1.75 M $67.47 M   -1.90% 0.86%
ARMISTICE CAPITAL, LLC 08/14/2026 1.74 M $66.89 M   -51.30% 0.85%
ALPINE GLOBAL MANAGEMENT, LLC 08/14/2026 1.38 M $52.98 M   -47.86% 0.68%
PERCEPTIVE ADVISORS LLC 08/14/2026 1.36 M $52.30 M   -15.02% 0.67%
D. E. SHAW & CO., INC. 08/14/2026 1.24 M $47.80 M   100.00% 0.61%
ARMISTICE CAPITAL, LLC 08/14/2026 1.20 M $46.24 M   -36.84% 0.59%
BANK OF AMERICA CORP /DE/ 08/14/2026 1.18 M $45.52 M   32.20% 0.58%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 1.02 M $39.40 M   65.51% 0.50%
ABRDN PLC 07/31/2026 857.03 K $33.02 M   -26.17% 0.42%
NORTHERN TRUST CORP 08/13/2026 794.00 K $30.59 M   18.02% 0.39%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 726.80 K $28.00 M   277.56% 0.36%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 680.59 K $26.22 M   3.05% 0.33%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 680.59 K $26.22 M   100.00% 0.33%
LOGOS GLOBAL MANAGEMENT LP 08/14/2026 665.00 K $25.62 M   -38.14% 0.33%
SILVERARC CAPITAL MANAGEMENT, LLC 08/13/2026 619.10 K $23.85 M   49.45% 0.30%
NUVEEN, LLC 08/11/2026 602.05 K $23.20 M   149.61% 0.30%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 564.25 K $21.74 M   3.62% 0.28%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 08/13/2026 473.98 K $18.26 M   -5.89% 0.23%
UBS GROUP AG 08/13/2026 472.12 K $18.19 M   -31.03% 0.23%
PICTET ASSET MANAGEMENT HOLDING SA 07/30/2026 462.36 K $17.81 M   -2.12% 0.23%
HRT FINANCIAL LP 08/14/2026 331.92 K $12.79 M   399.24% 0.16%
MILLENNIUM MANAGEMENT LLC 08/14/2026 328.68 K $12.66 M   100.00% 0.16%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 320.07 K $12.33 M   -4.33% 0.16%
JANE STREET GROUP, LLC 08/14/2026 310.40 K $11.96 M   1,049.63% 0.15%
BANK OF NEW YORK MELLON CORP 08/06/2026 295.79 K $11.40 M   36.80% 0.15%
HIGHVISTA STRATEGIES LLC 08/14/2026 277.87 K $10.71 M   23.42% 0.14%
STEMPOINT CAPITAL LP 08/14/2026 276.53 K $10.65 M   -62.96% 0.14%
TFG ASSET MANAGEMENT GP LTD 08/13/2026 255.93 K $9.86 M   17.13% 0.13%
SOLEUS CAPITAL MANAGEMENT, L.P. 08/11/2026 252.00 K $9.71 M   9.57% 0.12%
SUPERSTRING CAPITAL MANAGEMENT LP 08/14/2026 208.37 K $8.03 M   -41.73% 0.10%
GRANAHAN INVESTMENT MANAGEMENT, LLC 08/14/2026 206.37 K $7.95 M   -15.57% 0.10%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 08/14/2026 183.00 K $7.05 M   -60.72% 0.09%

Immunovant Inc institutional Ownership - FAQ's

During the previous two years, 290 institutional investors and hedge funds held shares of Immunovant Inc. The most heavily invested institutionals were:

FMR LLC: 16.19 M

Deep Track Capital, LP: 9.34 M

BlackRock, Inc.: 7.18 M

FARALLON CAPITAL MANAGEMENT LLC: 5.81 M

BAKER BROS. ADVISORS LP: 5.44 M

STATE STREET CORP: 4.62 M

54.48% of Immunovant Inc stock is owned by institutional investors.

Institutional investors have bought a total of 129.11 M shares in the last 24 months. This purchase volume represents approximately $3.41 B in transactions.